Related Experiment Video
Updated: Jul 8, 2026
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Mechanisms of early death despite thrombolytic therapy: experience from the Thrombolysis in Myocardial Infarction
N S Kleiman1, M Terrin, H Mueller
1TIMI Coordinating Center, Maryland Medical Research Institute, Inc., Baltimore 21210.
Insights
Early deaths after myocardial infarction are most often due to pump failure. Efforts to reduce mortality in the critical early hours should focus on preventing or managing pump failure, even with thrombolytic therapy.
Area of Science:
- Cardiology
- Clinical Medicine
- Medical Research
Background:
- Mortality following acute myocardial infarction (MI) remains a significant concern.
- Early death, particularly within the first 18 hours, requires detailed investigation.
- Understanding the mechanisms of early death is crucial for improving patient outcomes.
Purpose of the Study:
- To analyze the mechanisms of death in patients who died within 18 hours of enrollment in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) study.
- To identify the primary causes of early mortality in acute myocardial infarction patients receiving thrombolytic therapy.
Main Methods:
- Analysis of patient data from the TIMI II study, focusing on deaths occurring within 18 hours of enrollment.
- Categorization of patients based on hemodynamic status at enrollment (shock, advanced compromise, minimal compromise).
- Classification of causes of death, including pump failure, ventricular rupture, arrhythmia, and complications of therapy.
Main Results:
- Out of 3,339 patients, 63 died within 18 hours of enrollment (32 in the first 4 hours, 31 in the subsequent 14 hours).
- Pump failure was the leading cause of early death, accounting for 62% (39 deaths), followed by ventricular rupture (16%), arrhythmia (13%), and therapy complications (10%).
- Early mortality rates were similar between immediate and deferred beta-blocker therapy groups.
Conclusions:
- Mortality is highest in the early hours after myocardial infarction, even with thrombolytic therapy.
- Pump failure is the most frequent cause of early death.
- Strategies to reduce early mortality should target the prevention, limitation, or palliation of pump failure.
Abstract:
Mechanisms of death among patients who died within 18 h of enrollment in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) study were analyzed. Of 3,339 patients enrolled, 32 died within the 1st 4 h and 31 died within the subsequent 14 h. Thirteen of the 63 patients had shock at enrollment; 22 had advanced hemodynamic compromise without shock and 28 initially had minimal to no compromise. Prior infarction was present in 16 patients (25%). Pump failure was responsible for 39 early deaths (62%), ventricular rupture for 10 (16%), arrhythmia for 8 (13%) and complications of therapy for 6 (10%). Nine of 720 patients randomized to immediate intravenous beta-adrenergic blocking agent therapy had an early death compared with 6 of 714 assigned to deferred beta-blocker therapy. Thus, mortality is highest in the early hours after myocardial infarction, even in patients treated with thrombolytic therapy and is most frequently due to pump failure. These results imply that efforts to reduce mortality during this critical time period should be directed at prevention, limitation or palliation of early pump failure.
Related Concept Videos
01:30Acute Coronary Syndrome I: Introduction
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:29Venous Thrombosis III: Interprofessional Care
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
01:15Ischemic Stroke ll: Pathophysiology